Skip to content

Study · In vitro (cells) · 1997

2 results

Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells.

Gucev ZS, Oh Y, Kelley KM, Labarta JI, Vorwerk P, Rosenfeld RG

Endocrinology1 Apr 1997Cited by 23 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In SKHEP-1 cells, Des(1‑3)-IGF-I increased conditioned-medium IGFBP-3 concentrations dose dependently by more than threefold.

    In plain wordsIn cells, Des(1‑3)-IGF-I increased IGFBP-3 protein in the culture medium.

    Outcome
    IncreaseIGFBP-3 protein concentration
    Study

    humann: not reported in source

    SKHEP-1 human hepatocarcinoma cells
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    1-100 ng/mlAs given in this study (human).

    Measurements

    IGFBP-3 increase
    > 3 fold
    Des(1-3)-IGF-I treatment

    Source sentences

    Summary
    SKHEP-1 cells significantly increased the IGFBP-3 concentrations in conditioned medium (CM) when treated with GH (0.1-10 ng/ml), IGF-I (1-100 ng/ml), or Des(1-3)-IGF-I (1-100 ng/ml) in a dose-dependent manner (>3-fold).
    1 context sentence
    Summary · context
    This study investigates the regulation of IGFBP-3 protein, measured by RIA and Western ligand blot, and messenger RNA (mRNA) expression, measured by Northern analysis and reverse transcriptase-PCR, in SKHEP-1 human hepatocarcinoma cells.
  2. 02LabIn vitro (cells)Mechanism

    In SKHEP-1 cells, the increase in IGFBP-3 protein after Des(1‑3)-IGF-I treatment accompanied increased IGFBP-3 mRNA.

    In plain wordsIn cells, Des(1‑3)-IGF-I treatment increased IGFBP-3 gene activity alongside increased protein.

    Outcome
    IncreaseIGFBP-3 mRNA
    Study

    humann: not reported in source

    SKHEP-1 human hepatocarcinoma cells
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    1-100 ng/mlAs given in this study (human).

    Source sentences

    Summary
    The increase in IGFBP-3 protein concentrations in CM was accompanied by a corresponding increase in IGFBP-3 mRNA levels.
    2 context sentences
    Summary · context
    SKHEP-1 cells significantly increased the IGFBP-3 concentrations in conditioned medium (CM) when treated with GH (0.1-10 ng/ml), IGF-I (1-100 ng/ml), or Des(1-3)-IGF-I (1-100 ng/ml) in a dose-dependent manner (>3-fold).
    Summary · context
    This study investigates the regulation of IGFBP-3 protein, measured by RIA and Western ligand blot, and messenger RNA (mRNA) expression, measured by Northern analysis and reverse transcriptase-PCR, in SKHEP-1 human hepatocarcinoma cells.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 13:52 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.